Evidence map›Paper›PMID 30587707›Full record

ArticleAnatolian journal of cardiology2019

The role of rivaroxaban in left ventricular thrombi.

Mahmoud Abdelnaby, Abdallah Almaghraby, Ola Abdelkarim, Yehia Saleh, Basma Hammad, Haitham Badran

Registry-linked trialAbstract readCase Reports
In one paragraph

Article in Anatolian journal of cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05006677 (Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus), which is not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05006677 unknown statusnot on this mapstarted 2021, after this paper: background citation

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus

TypeobservationalSponsorChina National Center for Cardiovascular DiseasesRan2021 to 2023Enrolled480ConditionsVentricular ThrombusArmsnon-vitamin K antagonist oral anticoagulants (NOACs), vitamin K antagonists (VKAs), antiplatelet agents, non-antithrombotic therapy
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Ventricular non-compaction review.Heart failure reviews · 2022
    Review
  6. Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2022
    Article
  7. Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2022
    Review
  8. Rivaroxaban versus warfarin for the management of left ventricle thrombus.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mahmoud Abdelnaby
Abdallah AlmaghrabyDepartment of Cardiology, Faculty of Medicine, University of Alexandria; Alexandria-Egypt. dr.maghraby@gmail.com.
Ola Abdelkarim
Yehia Saleh
Basma Hammad
Haitham Badran

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myocardial InfarctionAdultAgedDiagnosis, DifferentialEchocardiographyFactor Xa InhibitorsFemaleHeart VentriclesHumansMaleMiddle AgedRivaroxabanThrombosisFactor Xa InhibitorsRivaroxaban

Identifiers

PMID30587707
PMCPMC6382905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.